TABLE 1.
Baseline characteristics.
| Characteristics | Total (N = 1341) |
|---|---|
| Demographics | |
| Age (years), mean ± SD | 57.2 ± 12.3 |
| Sex, n (%) | |
| Female | 564 (42.1) |
| Male | 777 (57.9) |
| BMI (kg/m2), mean ± SD | 25.8 ± 3.6 |
| Education level, n (%) | |
| Primary school or less | 134 (10.0) |
| High school | 609 (45.4) |
| Undergraduate or above | 598 (44.6) |
| Smoker, n (%) | |
| No | 923 (68.8) |
| Yes | 418 (31.2) |
| Alcohol intake, n (%) | |
| No | 1101 (82.1) |
| Yes | 240 (17.9) |
| Hypertension duration (years), median (IQR) | 6.1 (2.1‐14.4) |
| Medical history | |
| Family history of hypertension, n (%) | |
| No | 503 (37.5) |
| Yes | 807 (60.2) |
| Unknown | 31 (2.3) |
| History of allergy, n (%) | |
| No | 1189 (88.7) |
| Yes | 137 (10.2) |
| Unknown | 15 (1.1) |
| History of respiratory disease, n (%) | |
| No | 1230 (91.7) |
| Yes | 105 (7.8) |
| Unknown | 6 (0.4) |
| History of kidney disease, n (%) | |
| No | 1267 (94.3) |
| Yes | 71 (5.3) |
| Unknown | 3 (0.2) |
| History of diabetes, n (%) | |
| No | 1121 (83.6) |
| Yes | 214 (16.0) |
| Unknown | 6 (0.4) |
| History of CCVD, n (%) | |
| No | 971 (72.4) |
| Yes | 370 (27.6) |
| History of dyslipidemia, n (%) | |
| No | 788 (58.8) |
| Yes | 523 (39.0) |
| Unknown | 30 (2.2) |
| Vital signs | |
| Respiratory rate (breaths/min), mean ± SD | 17.8 ± 2.3 |
| Heart rate (beats/min), mean ± SD | 76.4 ± 9.9 |
| SeSBP (mmHg), mean ± SD | 140.1 ± 16.2 |
| Abnormal SeSBP, n (%) | 691 (51.5) |
| SeDBP (mmHg), mean ± SD | 86.8 ± 11.1 |
| Abnormal SeDBP, n (%) | 544 (40.6) |
| Hypertension severity class, n (%) | |
| No | 531 (39.6) |
| Mild | 562 (41.9) |
| Moderate | 190 (14.2) |
| Severe | 58 (4.3) |
| History of antihypertensive treatment | |
| History of hypertension treatment, n (%) | |
| Ever treatment | 1221 (91.1) |
| First treatment | 120 (8.9) |
| History of antihypertensive drugs, n (%) | |
| Monotherapy | 735 (54.8) |
| Double combination | 390 (29.1) |
| Triple combination | 78 (5.8) |
| Unknown | 138 (10.3) |
| Current treatment during study | |
| OM‐AML tablet, n (%) | 1341 (100.0) |
| Combinations, n (%) | |
| No combination | 1065 (79.4) |
| Lipid‐modifying drug | 117 (8.7) |
| Lipid‐modifying drug and others | 159 (11.9) |
| Home‐measured BP | |
| Home‐measured SeSBP (mmHg), mean ± SD | 131.5 ± 11.5 |
| Home‐measured SeDBP (mmHg), mean ± SD | 81.7 ± 13.2 |
Abbreviations: BMI, body mass index; BP, blood pressure; CCVD, cardiovascular and cerebrovascular diseases; IQR, interquartile range; SD, standard deviation; SeSBP, seated systolic blood pressure; SeDBP, seated diastolic blood pressure.